Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator

Forskolin, which lowers intraocular pressure in rabbits, monkeys, and human subjects, was tested for its effect on the rate of aqueous humor flow and on outflow facility. Topical sodium fluorescein was used to measure the rate of aqueous humor flow in forskolin or placebo treated eyes. Tonography wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental eye research 1984-12, Vol.39 (6), p.745-749
Hauptverfasser: Burstein, Neal L., Sears, Marvin L., Mead, Alden
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 749
container_issue 6
container_start_page 745
container_title Experimental eye research
container_volume 39
creator Burstein, Neal L.
Sears, Marvin L.
Mead, Alden
description Forskolin, which lowers intraocular pressure in rabbits, monkeys, and human subjects, was tested for its effect on the rate of aqueous humor flow and on outflow facility. Topical sodium fluorescein was used to measure the rate of aqueous humor flow in forskolin or placebo treated eyes. Tonography was used to determine outflow facility before forskolin administration and at 3 hr after administration of the drug. In eight human subjects who showed reduction of intraocular pressure in response to a single drop of forskolin, flow was reduced by an average of 34%, compared to the contralateral eye during the same period of time. No significant change in outflow facility occurred. The action of forskolin in reducing intraocular pressure was the direct result of a reduction in net aqueous flow.
doi_str_mv 10.1016/0014-4835(84)90073-3
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_75847545</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0014483584900733</els_id><sourcerecordid>75847545</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-cf460b58540f7b57628a465e61bc8bb59fc8bd6973620ea0d2bde5bd6415c35d3</originalsourceid><addsrcrecordid>eNp9kE1r3DAQhkVoSTeb_IMUdAghgTqRrA_Ll0AISVoI9NJAbkKWxlSt19pI9hb_-8pds8eeBs0886J5EDqn5IYSKm8Jobzgiokrxa9rQipWsCO0oqSWBcnPD2h1QD6hk5R-5S7jFT9Gx1LwUkm5Qm_37yOEMeG2C3-w7_HPcWN6DBMk7BOO4EYLDjcTbkNMv0Pn-y_Y4G0YoB-wcdBPnRkA28l2JgE2dvA7M4R4ij62pktwttQ1en16_PHwtXj5_vzt4f6lsEzJobAtl6QRSnDSVo2oZKkMlwIkbaxqGlG3uThZV0yWBAxxZeNA5A6nwjLh2Bpd7nO3MeRT0qA3PlnoOtPPd-lKKF4JLjLI96CNIaUIrd5GvzFx0pToWaiebenZllZc_xOqWV77vOSPzQbcYWkxmOcXy9wka7o2mt76dMBqWlJVzjF3ewyyi52HqJP10Ge3PoIdtAv-___4C1v7kac</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>75847545</pqid></control><display><type>article</type><title>Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Burstein, Neal L. ; Sears, Marvin L. ; Mead, Alden</creator><creatorcontrib>Burstein, Neal L. ; Sears, Marvin L. ; Mead, Alden</creatorcontrib><description>Forskolin, which lowers intraocular pressure in rabbits, monkeys, and human subjects, was tested for its effect on the rate of aqueous humor flow and on outflow facility. Topical sodium fluorescein was used to measure the rate of aqueous humor flow in forskolin or placebo treated eyes. Tonography was used to determine outflow facility before forskolin administration and at 3 hr after administration of the drug. In eight human subjects who showed reduction of intraocular pressure in response to a single drop of forskolin, flow was reduced by an average of 34%, compared to the contralateral eye during the same period of time. No significant change in outflow facility occurred. The action of forskolin in reducing intraocular pressure was the direct result of a reduction in net aqueous flow.</description><identifier>ISSN: 0014-4835</identifier><identifier>EISSN: 1096-0007</identifier><identifier>DOI: 10.1016/0014-4835(84)90073-3</identifier><identifier>PMID: 6542866</identifier><identifier>CODEN: EXERA6</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>adenylate cyclase ; Adenylyl Cyclases - metabolism ; Adult ; Aged ; aqueous flow ; Aqueous Humor - drug effects ; Aqueous Humor - physiology ; Biological and medical sciences ; cAMP ; Colforsin ; Diterpenes - pharmacology ; Enzyme Activation ; Eye and associated structures. Visual pathways and centers. Vision ; facility ; Female ; forskolin ; Fundamental and applied biological sciences. Psychology ; Humans ; intraocular pressure ; Intraocular Pressure - drug effects ; Male ; Middle Aged ; Vertebrates: nervous system and sense organs</subject><ispartof>Experimental eye research, 1984-12, Vol.39 (6), p.745-749</ispartof><rights>1984</rights><rights>1985 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-cf460b58540f7b57628a465e61bc8bb59fc8bd6973620ea0d2bde5bd6415c35d3</citedby><cites>FETCH-LOGICAL-c386t-cf460b58540f7b57628a465e61bc8bb59fc8bd6973620ea0d2bde5bd6415c35d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/0014483584900733$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=9121823$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6542866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Burstein, Neal L.</creatorcontrib><creatorcontrib>Sears, Marvin L.</creatorcontrib><creatorcontrib>Mead, Alden</creatorcontrib><title>Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator</title><title>Experimental eye research</title><addtitle>Exp Eye Res</addtitle><description>Forskolin, which lowers intraocular pressure in rabbits, monkeys, and human subjects, was tested for its effect on the rate of aqueous humor flow and on outflow facility. Topical sodium fluorescein was used to measure the rate of aqueous humor flow in forskolin or placebo treated eyes. Tonography was used to determine outflow facility before forskolin administration and at 3 hr after administration of the drug. In eight human subjects who showed reduction of intraocular pressure in response to a single drop of forskolin, flow was reduced by an average of 34%, compared to the contralateral eye during the same period of time. No significant change in outflow facility occurred. The action of forskolin in reducing intraocular pressure was the direct result of a reduction in net aqueous flow.</description><subject>adenylate cyclase</subject><subject>Adenylyl Cyclases - metabolism</subject><subject>Adult</subject><subject>Aged</subject><subject>aqueous flow</subject><subject>Aqueous Humor - drug effects</subject><subject>Aqueous Humor - physiology</subject><subject>Biological and medical sciences</subject><subject>cAMP</subject><subject>Colforsin</subject><subject>Diterpenes - pharmacology</subject><subject>Enzyme Activation</subject><subject>Eye and associated structures. Visual pathways and centers. Vision</subject><subject>facility</subject><subject>Female</subject><subject>forskolin</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Humans</subject><subject>intraocular pressure</subject><subject>Intraocular Pressure - drug effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0014-4835</issn><issn>1096-0007</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1984</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1r3DAQhkVoSTeb_IMUdAghgTqRrA_Ll0AISVoI9NJAbkKWxlSt19pI9hb_-8pds8eeBs0886J5EDqn5IYSKm8Jobzgiokrxa9rQipWsCO0oqSWBcnPD2h1QD6hk5R-5S7jFT9Gx1LwUkm5Qm_37yOEMeG2C3-w7_HPcWN6DBMk7BOO4EYLDjcTbkNMv0Pn-y_Y4G0YoB-wcdBPnRkA28l2JgE2dvA7M4R4ij62pktwttQ1en16_PHwtXj5_vzt4f6lsEzJobAtl6QRSnDSVo2oZKkMlwIkbaxqGlG3uThZV0yWBAxxZeNA5A6nwjLh2Bpd7nO3MeRT0qA3PlnoOtPPd-lKKF4JLjLI96CNIaUIrd5GvzFx0pToWaiebenZllZc_xOqWV77vOSPzQbcYWkxmOcXy9wka7o2mt76dMBqWlJVzjF3ewyyi52HqJP10Ge3PoIdtAv-___4C1v7kac</recordid><startdate>198412</startdate><enddate>198412</enddate><creator>Burstein, Neal L.</creator><creator>Sears, Marvin L.</creator><creator>Mead, Alden</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>198412</creationdate><title>Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator</title><author>Burstein, Neal L. ; Sears, Marvin L. ; Mead, Alden</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-cf460b58540f7b57628a465e61bc8bb59fc8bd6973620ea0d2bde5bd6415c35d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1984</creationdate><topic>adenylate cyclase</topic><topic>Adenylyl Cyclases - metabolism</topic><topic>Adult</topic><topic>Aged</topic><topic>aqueous flow</topic><topic>Aqueous Humor - drug effects</topic><topic>Aqueous Humor - physiology</topic><topic>Biological and medical sciences</topic><topic>cAMP</topic><topic>Colforsin</topic><topic>Diterpenes - pharmacology</topic><topic>Enzyme Activation</topic><topic>Eye and associated structures. Visual pathways and centers. Vision</topic><topic>facility</topic><topic>Female</topic><topic>forskolin</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Humans</topic><topic>intraocular pressure</topic><topic>Intraocular Pressure - drug effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burstein, Neal L.</creatorcontrib><creatorcontrib>Sears, Marvin L.</creatorcontrib><creatorcontrib>Mead, Alden</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental eye research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burstein, Neal L.</au><au>Sears, Marvin L.</au><au>Mead, Alden</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator</atitle><jtitle>Experimental eye research</jtitle><addtitle>Exp Eye Res</addtitle><date>1984-12</date><risdate>1984</risdate><volume>39</volume><issue>6</issue><spage>745</spage><epage>749</epage><pages>745-749</pages><issn>0014-4835</issn><eissn>1096-0007</eissn><coden>EXERA6</coden><abstract>Forskolin, which lowers intraocular pressure in rabbits, monkeys, and human subjects, was tested for its effect on the rate of aqueous humor flow and on outflow facility. Topical sodium fluorescein was used to measure the rate of aqueous humor flow in forskolin or placebo treated eyes. Tonography was used to determine outflow facility before forskolin administration and at 3 hr after administration of the drug. In eight human subjects who showed reduction of intraocular pressure in response to a single drop of forskolin, flow was reduced by an average of 34%, compared to the contralateral eye during the same period of time. No significant change in outflow facility occurred. The action of forskolin in reducing intraocular pressure was the direct result of a reduction in net aqueous flow.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>6542866</pmid><doi>10.1016/0014-4835(84)90073-3</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4835
ispartof Experimental eye research, 1984-12, Vol.39 (6), p.745-749
issn 0014-4835
1096-0007
language eng
recordid cdi_proquest_miscellaneous_75847545
source MEDLINE; Elsevier ScienceDirect Journals
subjects adenylate cyclase
Adenylyl Cyclases - metabolism
Adult
Aged
aqueous flow
Aqueous Humor - drug effects
Aqueous Humor - physiology
Biological and medical sciences
cAMP
Colforsin
Diterpenes - pharmacology
Enzyme Activation
Eye and associated structures. Visual pathways and centers. Vision
facility
Female
forskolin
Fundamental and applied biological sciences. Psychology
Humans
intraocular pressure
Intraocular Pressure - drug effects
Male
Middle Aged
Vertebrates: nervous system and sense organs
title Aqueous flow in human eyes is reduced by forskolin, a potent adenylate cyclase activator
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T12%3A31%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Aqueous%20flow%20in%20human%20eyes%20is%20reduced%20by%20forskolin,%20a%20potent%20adenylate%20cyclase%20activator&rft.jtitle=Experimental%20eye%20research&rft.au=Burstein,%20Neal%20L.&rft.date=1984-12&rft.volume=39&rft.issue=6&rft.spage=745&rft.epage=749&rft.pages=745-749&rft.issn=0014-4835&rft.eissn=1096-0007&rft.coden=EXERA6&rft_id=info:doi/10.1016/0014-4835(84)90073-3&rft_dat=%3Cproquest_cross%3E75847545%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=75847545&rft_id=info:pmid/6542866&rft_els_id=0014483584900733&rfr_iscdi=true